Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,368,292
-
Total 13F shares
-
18,603,225
-
Share change
-
+2,354,315
-
Total reported value
-
$260,445,000
-
Price per share
-
$14.00
-
Number of holders
-
43
-
Value change
-
+$32,083,306
-
Number of buys
-
30
-
Number of sells
-
9
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q1 2020
As of 31 Mar 2020,
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,603,225 shares.
The largest 10 holders included
NEA Management Company, LLC, FRAZIER MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Novo Holdings A/S, Rock Springs Capital Management LP, Polar Capital LLP, BAKER BROS. ADVISORS LP, Sofinnova Investments, Inc., BOXER CAPITAL, LLC, and BlackRock Inc..
This page lists
43
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.